Testing for bone cancer typically starts with imaging and ends with a biopsy, which is the only way to confirm a diagnosis. The process usually unfolds in stages: your doctor orders increasingly detailed scans to characterize the tumor, then takes a tissue sample to determine exactly what it is. Blood tests play a supporting role, and staging tests help map how far the cancer has spread.
Imaging Tests: The First Step
An X-ray is almost always the starting point. It can reveal abnormal bone growth, holes in the bone, or other structural changes that suggest a tumor. X-rays are fast and widely available, but they can’t tell your doctor whether a mass is cancerous or how deeply it extends into surrounding tissue.
If the X-ray raises concerns, your doctor will typically order an MRI. MRI produces detailed cross-sectional images of both bone and the soft tissue around it, making it especially useful for seeing how far a tumor extends into muscle, nerves, or blood vessels. Across multiple studies, MRI and traditional bone scans show similar sensitivity for detecting bone tumors (around 83 to 84%), but MRI edges ahead in specificity, meaning it’s slightly better at distinguishing cancer from non-cancerous conditions.
A CT scan may be ordered alongside or instead of an MRI, particularly to get a clearer picture of the bone’s internal structure. A PET scan, which highlights areas of unusually high metabolic activity throughout the body, is more commonly used later in the process to check whether cancer has spread to other bones or organs.
Blood Tests and What They Show
Blood work alone cannot diagnose bone cancer, but certain markers help your medical team assess what’s happening. Two markers are particularly relevant:
- Alkaline phosphatase (ALP) reflects bone activity and is sometimes elevated in people with osteosarcoma, the most common type of primary bone cancer.
- Lactate dehydrogenase (LDH) is a protein found in nearly all body tissues, and elevated levels can appear in people with Ewing sarcoma.
These values don’t confirm cancer on their own, but when combined with imaging results, they help your specialist narrow down the type of tumor and gauge its activity. Your doctor will also run standard blood panels to evaluate your overall health and organ function before any procedures.
The Biopsy: How Diagnosis Is Confirmed
No imaging test can definitively say whether a bone tumor is cancerous. That requires a biopsy, where a small sample of the suspicious tissue is removed and examined under a microscope. There are two main approaches.
A core needle biopsy is the most common method. A radiologist guides a hollow needle into the tumor using CT or ultrasound imaging, then extracts a small cylinder of tissue. This is a minimally invasive, cost-effective procedure with an excellent safety profile. Diagnostic accuracy ranges from 68% to 99% depending on tumor location and type. It’s typically done as an outpatient procedure, meaning you go home the same day.
An open (surgical) biopsy involves making an incision to access the tumor directly and remove a larger tissue sample. It remains the gold standard for diagnostic accuracy but is more invasive and reserved for cases where a needle biopsy didn’t yield enough tissue or produced inconclusive results.
In rare situations where an immediate answer is needed during a procedure, a fine-needle aspirate can be taken and examined on the spot. This involves a thinner needle and produces less tissue, so it’s not the default choice for bone tumors.
Why Biopsy Planning Matters
One detail that surprises many patients: the exact path the biopsy needle takes through your body is carefully planned by your surgical team. Tumor cells can potentially seed along the needle’s track, so most oncologic surgeons later remove that tissue tract during definitive surgery. If the biopsy path is poorly chosen, it can complicate later treatment options, sometimes making the difference between limb-saving surgery and amputation. This is why biopsies for suspected bone cancer should ideally be performed at or coordinated with the center where your surgery would take place.
Imaging should always be completed before a biopsy is performed. One reason to avoid rushing into a biopsy is the risk of contaminating surrounding tissues if the lesion turns out to be a primary bone tumor, which could limit surgical options down the line.
Primary Bone Cancer vs. Cancer That Spread to Bone
An important part of the diagnostic process is figuring out whether a tumor started in the bone (primary bone cancer) or spread there from somewhere else (metastatic bone disease). Metastatic bone tumors are far more common. Cancer from the breast, lung, prostate, kidney, or thyroid frequently travels to bone.
When a bone tumor is discovered and there’s no known cancer elsewhere, the biopsy becomes especially critical. Examining the tissue under a microscope, often enhanced with a technique called immunohistochemistry, can identify the cell type and point back to where the cancer originated. Biopsy identifies the primary source in about 38% of metastatic bone cases with unknown origin, the highest detection rate of any single test. When combined with CT scans, chest X-rays, and specialized staining techniques, that rate improves significantly.
Getting this distinction right changes the entire treatment plan. A primary bone sarcoma and a breast cancer metastasis to bone are treated with completely different strategies.
How Bone Cancer Is Staged
Once a diagnosis is confirmed, your medical team stages the cancer to understand how advanced it is. The standard system evaluates four factors: the size of the primary tumor, whether cancer has reached nearby lymph nodes, whether it has spread to distant sites, and the grade of the cancer cells (how abnormal they look and how quickly they’re likely to grow). These factors combine into an overall stage from I through IV, with higher numbers indicating more advanced disease.
Staging typically requires the imaging you’ve already had, plus possibly additional scans. A PET scan or CT of the chest is common at this point, since the lungs are the most frequent site of distant spread for primary bone cancers like osteosarcoma.
What the Biopsy Experience Feels Like
If you’re preparing for a bone biopsy, here’s what to expect practically. The procedure itself takes roughly 10 to 20 minutes, with additional time for preparation and post-procedure monitoring. You’ll receive either local anesthesia (numbing just the biopsy area) or IV sedation, depending on the tumor’s location and your comfort level.
With local anesthesia, you’ll lie on your back for 10 to 15 minutes afterward while pressure is applied to the site, then you can leave and return to normal activities when you feel ready. With IV sedation, you’ll spend time in a recovery area and need someone to drive you home. Plan to take it easy for 24 hours.
Tell your doctor about any medications or supplements you take beforehand, as some increase bleeding risk. Tenderness at the biopsy site is normal and may last a week or more. Over-the-counter pain relievers like acetaminophen typically manage the discomfort.
Liquid Biopsy: A Newer Option
Liquid biopsy, which analyzes fragments of tumor DNA circulating in a simple blood draw, is gaining traction for bone cancers. In a study of osteosarcoma patients, a multi-test liquid biopsy approach detected tumor material in 83% of samples taken at diagnosis. For individual testing methods alone, detection rates ranged from 50% to 80%, but combining multiple analysis techniques improved sensitivity.
Liquid biopsy isn’t yet a replacement for tissue biopsy in diagnosing bone cancer, but it’s increasingly used alongside traditional methods to track how tumors respond to treatment over time without repeated invasive procedures.